MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 421 filers reported holding MEDIVATION INC in Q2 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $81,795,000 | +28.8% | 1,356,473 | -1.7% | 0.09% | +13.8% |
| Q1 2016 | $63,481,000 | -19.2% | 1,380,615 | -15.1% | 0.08% | -7.0% |
| Q4 2015 | $78,565,000 | +213.4% | 1,625,249 | +175.5% | 0.09% | +258.3% |
| Q3 2015 | $25,072,000 | +97.1% | 589,935 | +429.6% | 0.02% | +118.2% |
| Q2 2015 | $12,722,000 | -66.5% | 111,401 | -62.1% | 0.01% | -69.4% |
| Q1 2015 | $37,985,000 | -18.0% | 294,299 | -36.7% | 0.04% | -21.7% |
| Q4 2014 | $46,333,000 | +335.4% | 465,149 | +332.1% | 0.05% | +318.2% |
| Q3 2014 | $10,642,000 | -80.5% | 107,639 | -84.8% | 0.01% | -82.3% |
| Q2 2014 | $54,554,000 | +1743.0% | 707,761 | +1439.3% | 0.06% | +1966.7% |
| Q1 2014 | $2,960,000 | -95.7% | 45,979 | -95.7% | 0.00% | -96.6% |
| Q4 2013 | $68,326,000 | +55.4% | 1,070,602 | +46.0% | 0.09% | +32.8% |
| Q3 2013 | $43,965,000 | +70.0% | 733,496 | +39.6% | 0.07% | +52.3% |
| Q2 2013 | $25,856,000 | – | 525,535 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,484,101 | $148,897,000 | 79.45% |
| BB BIOTECH AG | 1,449,706 | $86,895,000 | 4.73% |
| SECTORAL ASSET MANAGEMENT INC | 1,013,529 | $60,751,000 | 2.92% |
| Orbimed Advisors | 2,284,500 | $136,933,000 | 2.44% |
| Archipel Asset Management AB | 191,016 | $11,449,000 | 2.35% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 147,060 | $8,815,000 | 1.43% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 450,000 | $26,973,000 | 1.32% |
| QVT Financial LP | 305,128 | $18,289,000 | 1.24% |
| Bain Capital Public Equity Management, LLC | 825,687 | $49,492,000 | 1.24% |
| Tradeworx Inc. | 44,484 | $2,666,000 | 1.22% |